R. G. Sherrill

发表

Synthesis and anti-HIV-1 activity of 4,5,6,7-tetrahydro-5-methylimidazo benzodiazepin-2(1H)-one (TIBO) derivatives

K. Andries, E. Declerq, Michael J. Kukla, 1991 .

Optimization of 3-(1H-indazol-3-ylmethyl)-1,5-benzodiazepines as potent, orally active CCK-A agonists.

M. K. James, T. Willson, B. Henke, 1997, Journal of medicinal chemistry.

1,4-Benzodiazepine peripheral cholecystokinin (CCK-A) receptor agonists.

M. K. James, T. Rimele, R. G. Sherrill, 2001, Bioorganic & medicinal chemistry letters.

Regulation of TNF-α secretion by a specific melanocortin-1 receptor peptide agonist

J. Szewczyk, Michelle M Eilert, D. Ignar, 2003, Peptides.

Regulation of TNF-alpha secretion by a specific melanocortin-1 receptor peptide agonist.

J. Szewczyk, Michelle M Eilert, D. Ignar, 2003, Peptides.

Discovery of 1,5-benzodiazepines with peripheral cholecystokinin (CCK-A) receptor agonist activity (II): Optimization of the C3 amino substituent.

M. K. James, T. Willson, B. Henke, 1996, Journal of medicinal chemistry.

Palladium-mediated diazo insertions: preparation of 3-alkyl-2-carbomethoxycyclopetenones

D. Taber, R. G. Sherrill, J. Amedio, 1986 .

Substituted tetrahydro-beta-carbolines as potential agents for the treatment of human papillomavirus infection.

Pamela L. Golden, K. Romines, K. Gudmundsson, 2010, Bioorganic & medicinal chemistry letters.

Optimization of pyrrolidinone based HIV protease inhibitors.

E. Furfine, Ronda G. Davis-Ward, C. W. Andrews, 2005, Bioorganic & medicinal chemistry letters.

Bridged gamma-carbolines and derivatives possessing selective and combined affinity for 5-HT2 and D2 receptors.

M. Cheng, C. Kaiser, C. Tiffany, 1993, Journal of medicinal chemistry.

The first synthesis of 1,5-diazacyclooctan-2-one and differentially protected 1,5-diazacyclooctanes

R. G. Sherrill, 2007 .

The Naphthyridinone GSK364735 Is a Novel, Potent Human Immunodeficiency Virus Type 1 Integrase Inhibitor and Antiretroviral

E. Garvey, S. Foster, T. Fujiwara, 2007, Antimicrobial Agents and Chemotherapy.

Synthesis and antiviral activities of novel N-alkoxy-arylsulfonamide-based HIV protease inhibitors.

E. Furfine, R. Hazen, David J. Reynolds, 2005, Bioorganic & medicinal chemistry letters.

Synthesis and anti-HIV-1 activity of 4,5,6,7-tetrahydro-5-methylimidazo[4,5,1-jk][1,4]benzodiazepin- 2(1H)-one (TIBO) derivatives.

R. Pauwels, M. Miranda, M. Kukla, 1991, Journal of medicinal chemistry.

AN IMPROVED SYNTHESIS AND RESOLUTION OF 3-AMINO-1,3-DIHYDRO-5-PHENYL-2H-1,4-BENZODIAZEPIN-2-ONES

R. G. Sherrill, E. Sugg, 1995 .

(Aminoalkoxy)chromones. Selective sigma receptor ligands.

R. Patch, Z. Lu, R. G. Sherrill, 1992, Journal of medicinal chemistry.

A reinvestigation of the D-homoannular rearrangement and subsequent degradation pathways of (11β,16α)-9-Fluoro-11,15,17,21-tetrahydroxypregna-1,4-diene-3,20-dione (triamcinolone)

E. Delaney, R. G. Sherrill, T. C. Sedergran, 1994, Steroids.

Ultra-potent P1 modified arylsulfonamide HIV protease inhibitors: the discovery of GW0385.

M. Hanlon, E. Furfine, R. Xu, 2006, Bioorganic & medicinal chemistry letters.

Novel P1 chain-extended HIV protease inhibitors possessing potent anti-HIV activity and remarkable inverse antiviral resistance profiles.

Michael Brieger, E. Furfine, R. Hazen, 2005, Bioorganic & medicinal chemistry letters.

Synthesis and anti-HIV-1 activity of 4,5,6,7-tetrahydro-5-methylimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-on e (TIBO) derivatives. 2.

R. Pauwels, M. Miranda, C. Ho, 1991, Journal of medicinal chemistry.

Discovery of 1,5‐Benzodiazepines with Peripheral Cholecystokinin (CCK‐ A) Receptor Agonist Activity (II): Optimization of the C3 Amino Substituent.

T. Willson, B. Henke, J. Szewczyk, 1997 .